Back
Can Fite Biofarma Quote, Financials, Valuation and Earnings
Sponsored
CANF
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.00
Seasonality Move:
-4.74%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Can Fite Biofarma Price Quote
$2.00
-0.01 (-0.5%)
(Updated: November 21, 2024 at 2:00 PM ET)
Can Fite Biofarma Key Stats
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Day range:
$1.90 - $2.09
52-week range:
$1.83 - $4.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.92%
Volume:
95.5K
Avg. volume:
82.9K
1-year change:
0.25%
Market cap:
$12.2M
Revenue:
$743K
EPS:
$-3
How Much Does Can Fite Biofarma Make?
-
How Much Are Can Fite Biofarma's Sales Annually?
CANF Revenues are $743K -
How Much Profit Does Can Fite Biofarma's Make A Year?
CANF net income is -$7.6M
Is Can Fite Biofarma Growing As A Company?
-
What Is Can Fite Biofarma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.21% -
What Is Can Fite Biofarma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Can Fite Biofarma Stock Price Performance
-
Did Can Fite Biofarma Stock Go Up Last Month?
Can Fite Biofarma share price went down by -29.97% last month -
Did CANF's Share Price Rise Over The Last Year?
CANF share price rose by 0.25% over the past 1 year
What Is Can Fite Biofarma 52-Week High & Low?
-
What Is Can Fite Biofarma’s 52-Week High Share Price?
Can Fite Biofarma has traded as high as $4.69 over the past 52 weeks -
What Is Can Fite Biofarma’s 52-Week Low Share Price?
Can Fite Biofarma has traded as low as $1.83 over the past 52 weeks
Can Fite Biofarma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Can Fite Biofarma?
-
How Much Debt Does Can Fite Biofarma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Can Fite Biofarma Have?
Cash and short term investments quarterly total is $8.9M -
What Is Can Fite Biofarma’s Book Value Per Share?
Book value per share is 1.38
Is Can Fite Biofarma Cash Flow Positive?
Data Unavailable
Can Fite Biofarma Return On Invested Capital
-
Is Management Doing A Good Job?
CANF return on invested capital is -121.88% -
What Is Can Fite Biofarma Return On Assets?
ROA measures how assets are converting to revenues and is -72.07% -
What Is CANF Return On Equity?
ROE is a measure of profitability and is -121.88%
Can Fite Biofarma Earnings Date & Stock Price
-
What Is Can Fite Biofarma's Stock Price Today?
A single share of CANF can be purchased today for 2.01 -
What Is Can Fite Biofarma’s Stock Symbol?
Can Fite Biofarma trades on the nyam under the ticker symbol: CANF -
When Is Can Fite Biofarma’s Next Earnings Date?
The next quarterly earnings date for Can Fite Biofarma is scheduled on November 29, 2024 -
When Is CANF's next ex-dividend date?
Can Fite Biofarma's next ex-dividend date is November 21, 2024 -
How To Buy Can Fite Biofarma Stock?
You can buy Can Fite Biofarma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Can Fite Biofarma Competitors
-
Who Are Can Fite Biofarma's Competitors?
Below is a list of companies who compete with Can Fite Biofarma or are related in some way:
Can Fite Biofarma Dividend Yield
-
What Is CANF Dividend Yield?
Can Fite Biofarma’s dividend yield currently is 0% -
What Is Can Fite Biofarma’s Payout Ratio?
Can Fite Biofarma’s payout ratio is 0% -
When Did Can Fite Biofarma Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Can Fite Biofarma’s Dividend Per Share?
Can Fite Biofarma pays a dividend of $0.00 per share
Can Fite Biofarma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -710.81% |
Revenue: | -21.32% | -22.5% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 13.33 |
Upside from Last Price: | 563.35% |